Substituted pyrazolo-pyrazines and their use as GluN2B receptor modulators | Patent Publication Number 20200392113

US 20200392113 A1

Patent NumberUS 11214563 B2

Application Number16899847

Filled DateJun 12, 2020

Priority DateJun 14, 2019

Publication DateDec 17, 2020

Original AssigneeJohnson & Johnson

Current AssigneeJanssen Pharmaceuticals Johnson & Johnson

Inventor/ApplicantsHeather COATE
Heather Coate
Curt DVORAK
Curt Dvorak

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.